The boxed-warning row is important and asymmetric: because tirzepatide is approved, its rodent thyroid C-cell finding is formally carried on the label as a warning, whereas CagriSema simply has no label yet
When taking Semaglutide, you may experience some common side effects, including: Gastrointestinal Issues: Nausea, diarrhea, vomiting, constipation, and abdominal discomfort are frequent, especially when starting treatment or after a dose increase
At our clinic in West Carmel, we offer both
in Nature Medicine found that NNMT inhibition in white adipose tissue increased energy expenditure and reduced fat mass in animal models without altering food intake or physical activity (Kraus et al., Nature Medicine )
As your symptoms improve, you might only need them every couple of months